tiprankstipranks
Nirvana Life Sciences Inc (TSE:NIRV)
:NIRV
Canadian Market
Holding TSE:NIRV?
Track your performance easily

Nirvana Life Sciences Inc (NIRV) Financial Statements

6 Followers

Nirvana Life Sciences Inc Financial Overview

Nirvana Life Sciences Inc's market cap is currently ―. The company's EPS TTM is C$; its P/E ratio is ―; Nirvana Life Sciences Inc is scheduled to report earnings on April 8, 2025, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Oct 24Jul 24Apr 24Jan 24Oct 23
Income Statement-
Total Revenue-----
Gross Profit--$ -6.11K$ -12.21K-
EBIT$ -61.33K$ -54.81K$ -348.16K$ 5.02K$ -168.73K
EBITDA$ -61.33K$ -54.81K$ -342.05K$ 17.23K$ -168.73K
Net Income Common Stockholders$ -61.10K$ -54.69K$ -347.83K$ 5.37K$ -168.39K
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 619.00$ 2.75K$ 1.91K$ 3.14K$ 9.64K
Total Assets$ 19.54K$ 21.63K$ 20.66K$ 211.76K$ 61.85K
Total Debt$ ―$ ―$ ―$ ―$ ―
Net Debt$ ―$ ―$ ―$ ―$ ―
Total Liabilities$ 1.26M$ 1.21M$ 1.16M$ 1.03M$ 912.01K
Stockholders Equity$ -1.25M$ -1.19M$ -1.14M$ -812.35K$ -845.86K
Cash Flow-
Free Cash Flow$ -56.66K$ -1.10K$ -5.87K$ -8.46K$ -70.45K
Operating Cash Flow$ -56.66K$ -1.10K$ -5.87K$ -8.46K$ -70.45K
Investing Cash Flow-----
Financing Cash Flow$ 37.62K$ 5.27K$ 4.64K$ 1.96K$ 38.63K
Currency in USD

Nirvana Life Sciences Inc Earnings and Revenue History

Nirvana Life Sciences Inc Debt to Assets

Nirvana Life Sciences Inc Cash Flow

Nirvana Life Sciences Inc Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis